MarketInOut Stock Screener Log In | Sign Up

Cordlife Group Ltd

SES • Healthcare • Diagnostics & Research • Quote as of 10/19/2026
Cordlife Group Ltd stock price and volume chart

Company Profile

IndustryDiagnostics & Research
SectorHealthcare
ExchangeSES
Market Capitalization31.01 mln
Float64.21 mln
Earnings Date11/06/2026

Piotroski F-Score

2 / 9
Weak

Beneish M-Score

-2.42
Borderline

Relative Strength

20 / 100
Significantly lagging

Debt / Equity

0.04
Debt-free

Pre-Tax Margin

-26%
Deeply loss-making

ROE

-10.76
Negative

Business Description

Founded in Singapore in 2001, Cordlife Group Limited stores and processes biological materials such as cord blood and tissue samples for families across Singapore, Hong Kong, India, Malaysia, the Philippines, and beyond. The company also runs a diagnostics division that screens newborns and children for genetic conditions, vision and hearing issues, and allergies, while offering genetic lifestyle screening for adults. In addition, Cordlife provides laboratory services, medical consulting, and pharmaceutical research and development.

Key Fundamentals

EPS-0.04
ROE-10.76
RPS0.14
ROIC-9.07
ROA-5.54
Interest Cover-75.61
EBITDA, mln-5.58
EV / EBITDA2.56
EV / EBIT1.50
Revenue, mln36.96

Quote Details

Last 0.121
Change 0 (0%)
Open 0.121
Volume 10,000
Turnover 1,210
Average Volume 13,918

Financial Ratios

Pre-Tax Profit Margin-26
Leverage Ratio1.99
Current Ratio2.84
Price / Book0.31
Price / Tangible Book0.43
Debt / Equity0.04
Price / Sales0.84

Financial Strength

Altman Z-Score0.76
Piotroski F-Score 2 / 9
Beneish M-Score-2.42
Price to Intrinsic Value0.35
Shiller PE Ratio18.25

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -8.33% 18 / 100   
1 Month -24.37% 4 / 100   
2 Months -24.37% 17 / 100   
6 Months -48.51% 5 / 100   
1 Year -24.37% 22 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Blog